Prognostic significance of doubling time in patients undergoing radical surgery for metachronous peritoneal metastases of colorectal cancer-Reference-Cited by-同舟云学术

Prognostic significance of doubling time in patients undergoing radical surgery for metachronous peritoneal metastases of colorectal cancer

Published:2019-02-09 Issue:5 Volume:34 Page:801-809
ISSN:0179-1958
Container-title:International Journal of Colorectal Disease
language:en
Short-container-title:Int J Colorectal Dis

Author:

Miyake Hiroaki,Murono Koji,Nagata Hiroshi,Nozawa Hiroaki,Kawai Kazushige,Hata Keisuke,Tanaka Toshiaki,Nishikawa Takeshi,Shuno Yasutaka,Sasaki Kazuhito,Ishihara Soichiro

Funder

Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science

the Project for Cancer Research and Therapeutic Evolution from the Japan Agency for Medical Research and Development

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology

Link

http://link.springer.com/article/10.1007/s00384-019-03259-5/fulltext.html

Reference39 articles.

1. Cass AW, Million RR, Pfaff WW (1976) Patterns of recurrence following surgery alone for adenocarcinoma of the colon and rectum. Cancer 37:2861–2865

2. van Gestel YR, Thomassen I, Lemmens VE, Pruijt JF, van Herk-Sukel MP, Rutten HJ, Creemers GJ, de Hingh IH (2014) Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer. Eur J Surg Oncol 40:963–969. https://doi.org/10.1016/j.ejso.2013.10.001

3. Segelman J, Granath F, Holm T, Machado M, Mahteme H, Martling A (2012) Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancer. Br J Surg 99:699–705. https://doi.org/10.1002/bjs.8679

4. Franko J, Shi Q, Goldman CD, Pockaj BA, Nelson GD, Goldberg RM, Pitot HC, Grothey A, Alberts SR, Sargent DJ (2012) Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841. J Clin Oncol 30:263–267. https://doi.org/10.1200/JCO.2011.37.1039

5. Franko J, Shi Q, Meyers JP, Maughan TS, Seymour MT, Saltz L et al (2016) Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the analysis and research in cancers of the digestive system (ARCAD) database. Lancet Oncol 17:1709–1719. https://doi.org/10.1016/S1470-2045(16)30500-9

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and external validation of MRI‐based RAS mutation status prediction model for liver metastases of colorectal cancer;Journal of Surgical Oncology;2023-11-16

2. Comparison of Proportion of Elevated Carcinoembryonic Antigen Levels in Patients With Appendiceal and Colorectal Adenocarcinoma: A Systematic Review and Meta-analysis;Anticancer Research;2022-08-23

3. Tumor Growth Rate as a Predictive Marker for Recurrence and Survival After Liver Resection in Patients with Liver Metastases of Uveal Melanoma;Annals of Surgical Oncology;2022-08-18

4. Usefulness of carcinoembryonic antigen doubling time in prognosis prediction after curative resection of locally recurrent rectal cancer: A retrospective study;Digestive Surgery;2021-11-08

Risk Stratification Based on Synchronous Neoplasia and Clinical Physicochemical Characteristics Predicts a Higher Incidence of Metachronous Advanced Neoplasia in Patients Undergoing Colorectal Resection for Colorectal Cancer

;Cancer Management and Research;2020-11